Skip to main content
SpringerLink
Log in

The Economic Cost of Cirrhosis

  • Chapter
  • First Online:
Complications of Cirrhosis

  • 1966 Accesses

Abstract

Cirrhosis of the liver is a common condition that is associated with high rates of morbidity and mortality. The available data also underline the substantial economic burden associated with cirrhosis resulting from both direct health-care expenditures in caring for the disease as well as indirect costs related to lost income from premature death or disability. The economic costs of cirrhosis will likely continue to increase as a result of an aging chronic hepatitis C cohort and the rising prevalence of nonalcoholic fatty liver disease. This chapter provides an overview of the economic consequences of cirrhosis, and discusses the implications of these costs for the practicing physician.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Dufour MC. Chronic liver disease and cirrhosis. In: Everhart JE, editor. Digestive diseases in the United States: epidemiology and impact. Washington, DC: US Government Printing Office; 1994. p. 613–46.

    Google Scholar 

  2. Kim WR, Brown RS Jr, Terrault NA, El-Serag H. Burden of liver disease in the United States: summary of a workshop. Hepatology 2002;36:227–42.

    Article  PubMed  Google Scholar 

  3. El Khoury AC, Wallace C, Klimack WK, Razavi H. Economic burden of hepatitis C-associated diseases: Europe, Asia Pacific, and the Americas. J Med Econ. 2012;15(5):887–96.

    Article  PubMed  Google Scholar 

  4. Everhart JE, Ruhl CE. Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases. Gastroenterology 2009;136(2):376–86.

    Article  PubMed  Google Scholar 

  5. Everhart JE, editor. The burden of digestive diseases in the United States. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Washington, DC: US Government Printing Office, 2008; NIH Publication No. 09-6443. http://www.niddk.nih.gov/about-niddk/strategic-plans-reports/Pages/burden-digestive-diseases-in-united-states-report.aspx#CHAPTER25. Accessed 3 March 2015.

  6. Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project HCUPnet. Healthcare Cost and Utilization Project http://hcupnet.ahrq.gov/. Accessed 3 March 2015.

  7. Gordon SC, Pockros PJ, Terrault NA, Hoop RS, Buikema A, Nerenz D, Hamzeh FM. Impact of disease severity on healthcare costs in patients with chronic hepatitis C (CHC) virus infection. Hepatology 2012;56(5):1651–60.

    Article  PubMed  Google Scholar 

  8. McAdam-Marx C, McGarry LJ, Hane CA, Biskupiak J, Deniz B, Brixner DI. All-cause and incremental per patient per year cost associated with chronic hepatitis C virus and associated liver complications in the United States: a managed care perspective. J Manage Care Pharm. 2011;17(7):531–46.

    Google Scholar 

  9. Menzin J, White LA, Nichols C, Deniz B. The economic burden of advanced liver disease among patients with hepatitis C virus: a large state Medicaid perspective. BMC Health Serv Res. 2012;12:459.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Razavi H, Elkhoury AC, Elbasha E, Estes C, Pasini K, Poynard T, Kumar R. Chronic hepatitis C virus (HCV) disease burden and cost in the United States. Hepatology 2013;57(6):2164–70.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Viviane A, Alan BN. Estimates of costs of hospital stay for variceal and nonvariceal upper gastrointestinal bleeding in the United States. Value Health. 2008;11(1):1–3.

    Article  PubMed  Google Scholar 

  12. Stepanova M, Mishra A, Venkatesan C, Younossi ZM. In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009. Clin Gastroenterol Hepatol. 2012;10(9):1034–41.

    Article  PubMed  Google Scholar 

  13. Mishra A, Otgonsuren M, Venkatesan C, Afendy M, Erario M, Younossi ZM. The inpatient economic and mortality impact of hepatocellular carcinoma from 2005 to 2009: analysis of the US nationwide inpatient sample. Liver Int. 2013;33(8):1281-6. doi: 10.1111/liv.12201. Epub 2013 May 26. PubMed PMID: 23710596.

    Article  PubMed  Google Scholar 

  14. Thein HH, Isaranuwatchai W, Campitelli MA, Feld JJ, Yoshida E, Sherman M, Hoch JS, Peacock S, Krahn MD, Earle CC. Health care costs associated with hepatocellular carcinoma: a population-based study. Hepatology 2013;58(4):1375–84.

    Article  PubMed  Google Scholar 

  15. Lang K, Danchenko N, Gondek K, Shah S, Thompson D. The burden of illness associated with hepatocellular carcinoma in the United States. J Hepatol. 2009;50(1):89–99.

    Article  PubMed  Google Scholar 

  16. Kanwal F, El-Serag HB. Hepatocellular cancer care: cost is important but only one factor of disease burden. J Hepatol. 2009;50(1):10–2.

    Article  PubMed  Google Scholar 

  17. Soni, A. Top 10 most costly conditions among men and women, 2008: Estimates for the U.S. Civilian Noninstitutionalized Adult Population, Age 18 and Older. Statistical Brief #331. July 2011. Agency for Healthcare Research and Quality, Rockville, MD. http://www.meps.ahrq.gov/mepsweb/data_files/Accessed March 3, 2015.

    Google Scholar 

  18. Rakoski MO, McCammon RJ, Piette JD, Iwashyna TJ, Marrero JA, Lok AS, Langa KM, Volk ML. Burden of cirrhosis on older Americans and their families: analysis of the health and retirement study. Hepatology 2012;55(1):184–91.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Nguyen GC, Segev DL, Thuluvath PJ. Nationwide increase in hospitalizations and hepatitis C among inpatients with cirrhosis and sequelae of portal hypertension. Clin Gastroenterol Hepatol. 2007;5:1092–9.

    Article  PubMed  Google Scholar 

  20. Bajaj JS, Wade JB, Gibson DP, Heuman DM, Thacker LR, Sterling RK, Stravitz RT, Luketic V, Fuchs M, White MB, Bell DE, Gilles H, Morton K, Noble N, Puri P, Sanyal AJ. The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers. Am J Gastroenterol. 2011;106:1646–53.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Dorn SD. Gastroenterology in a new era of accountability: part 3. Accountable care organizations. Clin Gastroenterol Hepatol. 2011;9:750–3.

    Article  PubMed  Google Scholar 

  22. Volk ML, Tocco RS, Bazick J, Rakoski MO, Lok AS. Hospital readmissions among patients with decompensated cirrhosis. Am J Gastroenterol. 2012;107:247–52.

    Article  PubMed Central  PubMed  Google Scholar 

  23. 2014 American Association for the Study of Liver Diseases and Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C. http://www.hcvguidelines.org/full-report-view. Accessed 27 Feb 2014.

  24. Knox R. $ 1000 pill for hepatitis C spurs debate over drug prices. NPR. December 30, 2013.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, Baylor College of Medicine, 2002 Holcombe Blvd. (152), 77030, Houston, TX, USA

    Fasiha Kanwal MD, MSHS

  2. Division of Gastroenterology and Hepatology, University of Michigan Health System, 1500 E Medical Center Drive, 3912 Taubman, 48109, Ann Arbor, MI, USA

    Michael L. Volk MD, MSc

Authors
  1. Fasiha Kanwal MD, MSHS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael L. Volk MD, MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael L. Volk MD, MSc .

Editor information

Editors and Affiliations

  1. Department of Transplant, Mayo Clinic, Jacksonville, Florida, USA

    Andrew P. Keaveny

  2. Institut de Malalties Digestives i Metaboliques, University of Barcelona, Barcelona, Spain

    Andrés Cárdenas

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Kanwal, F., Volk, M. (2015). The Economic Cost of Cirrhosis. In: Keaveny, A., Cárdenas, A. (eds) Complications of Cirrhosis. Springer, Cham. https://doi.org/10.1007/978-3-319-13614-1_32

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-13614-1_32

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-13613-4

  • Online ISBN: 978-3-319-13614-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation